Kenneth Glass, Director at Oncternal Therapeutics, holds 204.82K shares in Oncternal Therapeutics (Ticker: ONCT), holds 499.58K shares in First Horizon (Ticker: FHN), holds 0.00 shares in FedEx (Ticker: FDX). Most recently, Kenneth Glass Bought ― shares of Oncternal Therapeutics on Mar 02, 2016 for an estimated value of 26.40K.
What is the percentage of profitable transactions made by Kenneth Glass?
The percentage of profitable transactions made by Kenneth Glass is 22%.
What is the average return per transaction made by Kenneth Glass?
The average return per transaction made by Kenneth Glass is -16.90%.
What stocks does Kenneth Glass hold?
Kenneth Glass holds: ONCT, FHN, FDX stocks.
What was Kenneth Glass’s latest transaction?
Kenneth Glass latest transaction was an Informative Buy of $26.40K.
What was Kenneth Glass's most profitable transaction?
Kenneth Glass’s most profitable transaction was an Informative Buy of ONCT stock on April 23, 2015. The return on the trade was 12.60%.
What is Kenneth Glass's role in Oncternal Therapeutics?
Kenneth Glass's role in Oncternal Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.